Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Amended on May 15, 2023 – the version known today is shown.

You are looking at Q4 2022. Go to the latest filing (Q3 2026)

26.0B USDQ4 2022
Total value of stock positions
26.0B USD
Positions
1,022
Share of the ten largest
14.3%

The ten largest positions Q4 2022

  1. Meta Platforms 2.2%▲ +140.7%
  2. Broadcom 1.7%▲ +166.0%
  3. Salesforce 1.7%new
  4. Amazon 1.6%▲ +174.8%
  5. Fidelity National Information Services 1.6%▲ +81.6%
  6. Biogen 1.3%▼ −26.9%
  7. Visa Inc. 1.2%▲ +32.7%
  8. Take-Two Interactive 1.1%▲ +80.1%
  9. Uber 0.9%▲ +18,546.7%
  10. Dominion Energy 0.9%▲ +197.1%
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q4 2022

Positions Q4 2022 per 13F filing, 50 of 277
Symbol Weight Shares Reported value Change Held since
Xenon Pharmaceuticals Inc 0.2% 1,178,324 46.5M USD −28.2% reduced Q1 2015 32 quarters
Sanofi < 0.1% 500,000 24.2M USD −71.1% reduced Q1 2018 20 quarters
LVS Las Vegas Sands 0.3% 1,502,803 72.2M USD −31.7% reduced Q3 2018 18 quarters
Insmed Inc < 0.1% 1,291,580 25.8M USD −16.2% reduced Q3 2018 18 quarters
Repligen Corp < 0.1% 84,178 14.3M USD −72.6% reduced Q3 2018 18 quarters
Enerplus Corp 0.1% 1,650,519 29.1M USD −28.8% reduced Q4 2018 17 quarters
Bread Financial Holdings Inc < 0.1% 249,821 9.4M USD 0.0% reduced Q4 2018 17 quarters
Select Sector SPDR TR < 0.1% 210,000 18.4M USD −90.0% reduced Q1 2019 16 quarters
Childrens Pl Inc New < 0.1% 18,200 662.8K USD −91.3% reduced Q1 2019 16 quarters
JBL Jabil 0.5% 1,776,900 121.2M USD −13.9% reduced Q2 2019 15 quarters
Performance Food Group Co < 0.1% 228,841 13.4M USD −42.7% reduced Q2 2019 15 quarters
Affimed N V < 0.1% 4,207,220 5.2M USD −21.9% reduced Q3 2019 14 quarters
Bicycle Therapeutics PLC 0.1% 1,007,978 29.8M USD −19.7% reduced Q4 2019 13 quarters
Neoleukin Therapeutics Inc < 0.1% 136,675 69.6K USD −93.4% reduced Q4 2019 13 quarters
MSFT Microsoft 0.5% 505,525 121.2M USD −47.2% reduced Q1 2020 12 quarters
AZN AstraZeneca 0.4% 1,539,490 104.4M USD −68.0% reduced Q1 2020 12 quarters
Avantor Inc 0.2% 2,069,355 43.6M USD −11.8% reduced Q1 2020 12 quarters
Applied Therapeutics Inc < 0.1% 719,938 547.2K USD −58.1% reduced Q1 2020 12 quarters
Ishares TR < 0.1% 10,000 498.2K USD −50.0% reduced Q1 2020 12 quarters
ADI Analog Devices 0.9% 1,355,581 222.4M USD −4.7% reduced Q2 2020 11 quarters
CB Chubb Limited 0.3% 387,634 85.5M USD −8.4% reduced Q2 2020 11 quarters
TMUS T-Mobile US 0.2% 357,008 50.0M USD −84.4% reduced Q2 2020 11 quarters
Krystal Biotech Inc 0.2% 556,252 44.1M USD −55.8% reduced Q2 2020 11 quarters
MRK Merck & Co. 0.2% 352,873 39.2M USD −40.7% reduced Q2 2020 11 quarters
Uniqure NV 0.1% 1,672,830 37.9M USD −60.7% reduced Q2 2020 11 quarters
GM General Motors 0.1% 820,690 27.6M USD −80.1% reduced Q2 2020 11 quarters
Allete Inc < 0.1% 287,200 18.5M USD −16.3% reduced Q2 2020 11 quarters
Elastic N V < 0.1% 324,965 16.7M USD −26.9% reduced Q2 2020 11 quarters
Bill Com HLDGS Inc < 0.1% 114,822 12.5M USD −89.3% reduced Q2 2020 11 quarters
Radnet Inc < 0.1% 565,930 10.7M USD −68.8% reduced Q2 2020 11 quarters
Angi Inc < 0.1% 1,504,814 3.5M USD −19.8% reduced Q2 2020 11 quarters
BIIB Biogen 1.3% 1,226,124 339.5M USD −26.9% reduced Q3 2020 10 quarters
TDY Teledyne Technologies 0.3% 176,628 70.6M USD −6.7% reduced Q3 2020 10 quarters
Antero Resources Corp 0.3% 2,256,115 69.9M USD −2.9% reduced Q3 2020 10 quarters
MAT Mattel 0.1% 2,178,742 38.9M USD −10.9% reduced Q3 2020 10 quarters
Arcutis Biotherapeutics Inc < 0.1% 1,103,576 16.3M USD −70.8% reduced Q3 2020 10 quarters
Transalta Corp < 0.1% 1,569,275 14.0M USD −13.3% reduced Q3 2020 10 quarters
Inspire Med Sys Inc 0.4% 412,924 104.0M USD −15.5% reduced Q4 2020 9 quarters
Chinook Therapeutics Inc 0.1% 1,267,660 33.2M USD −48.1% reduced Q4 2020 9 quarters
Pvh Corporation < 0.1% 223,813 15.8M USD −42.4% reduced Q4 2020 9 quarters
Tronox Holdings PLC < 0.1% 625,349 8.6M USD −10.0% reduced Q4 2020 9 quarters
Alphatec HLDGS Inc < 0.1% 379,300 4.7M USD −58.6% reduced Q4 2020 9 quarters
Protagonist Therapeutics Inc < 0.1% 316,500 3.5M USD −87.5% reduced Q4 2020 9 quarters
Angiodynamics Inc < 0.1% 139,754 1.9M USD −78.7% reduced Q4 2020 9 quarters
ANET Arista Networks 0.8% 1,812,261 219.9M USD −8.4% reduced Q1 2021 8 quarters
MLM Martin Marietta Materials 0.4% 282,253 95.4M USD −5.4% reduced Q1 2021 8 quarters
Sarepta Therapeutics Inc 0.4% 703,755 91.2M USD −17.4% reduced Q1 2021 8 quarters
VMC Vulcan Materials Company 0.2% 361,626 63.3M USD −12.6% reduced Q1 2021 8 quarters
VST Vistra Corp. 0.2% 2,666,835 61.9M USD −3.9% reduced Q1 2021 8 quarters
Aclaris Therapeutics Inc 0.1% 1,782,600 28.1M USD −3.8% reduced Q1 2021 8 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 277 positions.

Plus 400 option positions, value of the underlying shares as reported 2.9B USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Put 479.8M USD
  • SPDR S&P 500 ETF TR Call 266.2M USD
  • Humana Put 196.9M USD
  • UnitedHealth Group Put 196.8M USD
  • Invesco Db Multi-Sector Comm Call 90.7M USD
  • Caterpillar Inc. Put 70.4M USD
  • Select Sector SPDR TR Put 57.4M USD
  • IBM Put 53.6M USD
  • Medical Pptys Trust Inc Put 51.2M USD
  • AstraZeneca Call 49.9M USD
Plus 52 positions in convertible bonds and bonds worth 472.4M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Novavax Inc principal 29.9M USD 29.8M USD
  • Ringcentral Inc principal 27.7M USD 23.9M USD
  • Unity Software Inc principal 30.0M USD 22.6M USD
  • Splunk Inc principal 21.0M USD 20.3M USD
  • Spotify USA Inc principal 24.5M USD 19.8M USD
  • Docusign Inc principal 18.5M USD 17.5M USD
  • Dish Network Corporation principal 27.0M USD 17.3M USD
  • Dish Network Corporation principal 19.0M USD 17.1M USD
  • Splunk Inc principal 18.0M USD 17.0M USD
  • Sarepta Therapeutics Inc principal 9.0M USD 16.8M USD

Breakdown by sector

  • Technology 12.1%
  • Financials 7.3%
  • Consumer Discretionary 7.0%
  • Industrials 6.5%
  • Health Care 5.7%
  • Communication Services 5.4%
  • Utilities 3.5%
  • Consumer Staples 2.5%
  • Energy 2.3%
  • Materials 1.2%
  • Real Estate 0.7%
  • not in our coverage 45.9%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close